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Abstract 
Photodynamic  therapy  (PDT)  has  emerged  as  an  alternative  and  promising  noninvasive 
treatment for cancer as well as non-cancer diseases, which involves the uptake of photo-
sensitizers (PSs) by cancer cells followed by irradiation. The use of nanomaterials as carriers of 
PSs is a very promising approach to improve the development of PDT in clinical medicine. In 
this study, a novel folic acid-conjugated graphene oxide (GO) was strategically designed and 
prepared as targeting drug delivery system to achieve higher specificity. The second genera-
tion photosensitizer (PS) Chlorin e6 (Ce6) was effectively loaded into the system via hy-
drophobic interactions and π-π stacking. The nanocarriers can significantly increase the ac-
cumulation of Ce6 in tumor cells and lead to a remarkable photodynamic efficacy on MGC803 
cells upon irradiation. These suggested that folic acid-conjugated GO loaded Ce6 had great 
potential as effective drug delivery system in targeting PDT. 
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Introduction 
Photodynamic therapy (PDT) is an increasingly 
recognized  alternative  to  treat  various  cancers  in 
clinical  practice  [1].  Compared  with  conventionally 
therapeutic  modalities  (chemotherapy,  surgery,  or 
radiotherapy),  PDT  has  the  following  advantages 
[2-3]: (1) the minimal invasive nature, (2) the selectiv-
ity of the interest area, (3) the ability to treat patients 
with repeated doses  without initiating resistance or 
exceeding  total  dose  limitations  (as  associated  with 
radiotherapy).  PDT  involves  the  systemic,  local,  or 
topical administration of photosensitizers (PSs), and 
then irradiates using light of appropriate wavelength 
and  dosage,  and  finally  generates  reactive  oxygen 
species (ROSs) that induce cell death and necrosis of 
tumor components [4-5]. 
The  most  commonly  used  PSs  are  porphy-
rin-based  molecules  [6].  Many  of  them  are  limited 
because  of  prolonged  cutaneous  photosensitivity, 
poor water solubility and inadequate selectivity [7], 
which are encountered in clinical applications of nu-
merous  traditional  chemicals  [8-10].  Therefore,  nu-
merous approaches have been proposed to incorpo-
rate  PSs into various delivery carriers  such as lipo-
some,  polymer  nanoparticles,  gold  nanoparticles, 
quantum  dots,  magnetic  nanoparticles,  silica  nano-
particles, and so on [11-14], which realize high selec-
tivity, high efficacy and low risk of adverse events. 
Carbon-based  nanomaterials,  including  fuller-
enes [15], carbon nanotubes [16-17], carbon nanohorns 
[18],  and  their  derivatives,  exhibit  great  application Theranostics 2011, 1 
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prospects in PDT. For example, Fullerenes and their 
derivatives, due to their extended π-conjugation, have 
been reported as PSs in PDT [19-20]. Tan group have 
engineered  a  novel  molecular  complex  of  a  PS,  an 
ssDNA aptamer, and single-walled carbon nanotubes 
(SWNTs) for controllable singlet oxygen (1O2) genera-
tion  [21].  We  also  have  explored  polyamidoamine 
dendrimer modified multi-walled carbon nanotubes 
as  new  vehicles  to  deliver  5-aminolevulinic  acid 
(5-ALA)  to  tumor  MGC803  cells  [22].  Zhang  et  al. 
fabricated  Zinc  phthalocyanine  (ZnPc)  and  bovine 
serum albumin (BSA) co-loaded by single-wall carbon 
nanohorns with holes opened (SWNHox) to achieve a 
double  PDT  and  photohyperthermia  (PHT)  cancer 
phototherapy  system  that  uses  a  single  laser  [23]. 
Therefore,  carbon-based  nanomaterials  have  high-
lighted the direction as efficient delivery systems in 
PDT. 
Graphene,  a  very  recent  rising  star,  with  an 
atomically thin, 2D honeycomb lattice that consists of 
sp2-hybridized carbons, exhibits remarkable electron-
ic, thermal, optical, and mechanical properties [24-25]. 
Particularly,  graphene  oxide  (GO),  graphene’s  wa-
ter-soluble derivative, has been found important po-
tential applications in drug delivery [26-28] and en-
zyme immobilization [29] due to their large specific 
surface area and abundant functional groups (epox-
ide, hydroxyl, and carboxylic groups). Dai group for 
the first time employed PEG modified nanoscale GO 
(< 50 nm) as drug carriers to load doxorubicin (DOX) 
via  noncovalent  physisorption  (π-stacking)[26]  and 
camptothecin(CPT)  analogue  SN38  via  noncovalent 
van  der  Waals  interaction  [27].  Whereafter,  Chen 
group  prepared  GO-doxorubicin  hydrochloride  na-
nohybrid  and  further  investigated  the  loading  and 
release behaviors of doxorubicin hydrochloride in the 
nanohybrid system [30]. Zhijun Zhang et al fabricated 
folic  acid-conjugated  nanoscale  GO  to  control 
co-loading of DOX and CPT, and demonstrated that 
the  system  shows  specific  targeting  to  MCF-7  cells 
and  remarkably  high  cytotoxicity  [28].  Recently, 
Zhuang  Liu  et  al.  found  that  nanographene  sheets 
seem to home in on tumors, and can heat up and kill 
them from within with the help of a laser [31]. How-
ever, the controlled loading and targeted delivery PSs 
by GO-based drug carriers remain unexplored. 
Herein,  we  designed  and  prepared  folic  ac-
id-conjugated GO as drug delivery system for target-
ing PDT. In our strategy, sulfonic acid groups were 
introduced  to  GO,  which  rendered  it  stable  under 
physiological  conditions,  and  folic  acid  (FA)  mole-
cules were conjugated with the GO for targeting spe-
cific  cells  with  folate  receptors.  Furthermore,  con-
trolled  loading  and  targeted  delivery  PSs  using  the 
GO as a carrier were investigated. Chlorin e6 (Ce6), a 
promising  PS  with  a  high  sensitizing  efficacy,  was 
loaded  onto  the  GO  in  a  controlled  way.  To  our 
knowledge, this is the first report on the controlled 
loading  and  targeted  delivery  of  Ce6  on  gra-
phene-based carriers (Scheme 1/Fig. A). 
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Fig. A. Scheme 1 Chemical structure of Ce6. 
 
 
Methods 
Synthesis of graphene oxide 
GO  was  prepared  using  nature  graphite  pow-
ders  as  the  raw  materials  by  a  modified  Hummers 
method  [32-34].  Briefly,  2  g  of  graphite  and  1  g  of 
NaNO3 were put into a flask at 0 oC. Then, 50 mL of 
concentrated H2SO4 was added to the mixture, which 
was stirred for 30 min at 5  oC. Subsequently, 7 g of 
KMnO4 was added to the reaction system step-wisely 
over 1 h, meanwhile the temperature of the mixture 
was  kept  below  20  oC.  Then,  the  temperature  was 
lifted to 35 oC and stirred for 2 h. Afterwards, 90 mL of 
deionized distilled (DD) water was slowly added into 
the solution, and the temperature of the reaction sys-
tem jumped to 70 oC instantly. Finally, 7 mL of H2O2 
(30 %) and 55 mL of DD water were poured into the 
reaction system, resulting in the formation of bright 
yellow suspension. The GO was separated by filtra-
tion, washed for three times with diluted HCl (3%), 
and then dispersed in DD water. Exfoliation of GO 
was approached by sonicating (200 w) the GO in DD 
water at room temperature for 1 h generating homo-
geneous GO dispersions. 
Conjugation of folic acid with graphene oxide 
(FA-GO) 
FA  molecules  were  conjugated  to  the  GO  ac-
cording to the literature [28]. Briefly, 5 g of NaOH and 
5 g of ClCH2COONa were added to 100 mL of GO Theranostics 2011, 1 
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solution  (1mg/mL).  After  sonicated  for  2  h,  the  re-
sulting  product  (GO-COOH)  was  neutralized  with 
dilute HCl and washed for five times with DD water 
by  centrifugation.  Then,  the  GO-COOH  suspension 
was dialyzed against DD water for over 48 h to re-
move any ions. Afterwards, 200 mg sulfanilic acid and 
80  mg  sodium  nitrite  were  dissolved  in  20  mL  of 
0.25% NaOH. The mixture solution was added drop-
wise to 26 mL of 0.1 N HCl solutions in an ice bath. 
The diazonium salt solution was added to the disper-
sion of GO-COOH in an ice bath with stirring for 2 h. 
After dialyzing against DD water for over 48 h, the 
sulfonated GO-COOH (GOSO3H) was stored at 4 oC. 
The GO-SO3H was then conjugated with FA using a 
modification  of  the  standard  EDC–NHS  reaction  as 
described  by  Jönsson  et  al  [17,  35].  100  mg  of 
GO-SO3H dispersion was activated by an EDC/NHS 
solution and treated by ultrasonication for 2 h. Finally, 
20 mL of 0.5% FA was added to form a mixed solution 
and allowed to react at room temperature for 12 h. 
The unreacted materials were separated out by dialy-
sis against sodium bicarbonate solution (pH 8.0) for 48 
h, followed by dialysis against DD water for 24 h. 
Photosensitizers Ce6 loaded by FA-GO 
(FA-GO-Ce6) (Scheme 2/Fig. B) 
 
 
Fig. B. Scheme 2. Photosensitizers Ce6 loaded by folic 
acid-conjugated graphene oxide. 
 
Ce6 was dissolved in DD water and mixed with 
FA-GO  aqueous  suspension  (0.5  mg/mL)  at  room 
temperature for 24 h. Then the whole system was di-
alyzed against DD water for 24 h. The standard curve 
was established in one range of drug concentration. 
UV-vis  measurements  of  FA-GO-Ce6  in  the  mixed 
solvent (0.1 mL ethanol + 2.9 mL DD) were carried 
out. The loading efficiency of Ce6 was calculated ac-
cording to UV absorbance at 663 nm. Every experi-
ment was repeated for three times. 
Characterization 
Atomic  force  microscopic  (AFM)  images  were 
taken on a MultiMode Nanoscope V scanning probe 
microscopy  (SPM)  system  (Veeco,  USA).  Transmis-
sion  electron  microscopy  (TEM)  images  were  ac-
quired using a JEM-2010 (JEOL Ltd., Japan) operated 
at an accelerating voltage of 200 kV. Scanning electron 
microscopy  (SEM)  images  were  obtained  with 
FESEM:  ZEISS  operated  at  5.0  kV.  UV-vis  spectra 
were measured at 20 °C with a Shimadzu UV-2450 
UV-visible  spectrophotometer  equipped  with  a 
10-mm quartz cell, where the light path length was 1 
cm.  Fluorescence  spectra  were  recorded  on  a 
HITACHIH  FL-4600  spectrofluorimeter.  The  fourier 
transform infrared (FTIR) spectra were recorded on a 
Bruker EQUINOX 55 FTIR Spectrometer. The surface 
charge of samples was measured with Zeta potential 
measurements  in  water  (NICOMP  380ZLS  Zeta  po-
tential/Particle sizer). 
Cellular uptake in vitro 
Human stomach cancer MGC803  cells (3 × 103 
cells per well) were seeded in 96-well plates and di-
vided into three groups: (1) Cells were treated with 
GO-Ce6 in RPMI-1640 medium without FA. (2) Cells 
were treated with FA-GO-Ce6 in RPMI-1640 medium 
with FA. (3) Cells were treated with  FA-GO-Ce6 in 
RPMI-1640  medium  without  FA.  All  Cells  were  in-
cubated overnight at 37 °C in a humidified 5% CO2 
atmosphere, and continued to culture for 1 day. After 
being rinsed with PBS (pH 7.4), the cells were incu-
bated with 100 μL 50 μg/mL of different composites 
for 30 min at 37 °C in the dark under the same condi-
tions. After the wells were washed three times  and 
monitored  by  fluorescence  microscopy  (NIKON 
ECLIPSE  TS100)  and  CRi  Nuance  multispectral  im-
aging systems (Cambridge Research & Instrumenta-
tion,  Inc.,  Woburn,  MA,  USA).  A  spectral  cube  for 
cells,  which  contains  the  complete  spectral  infor-
mation at 10-nm wavelength intervals from 520 to 720 
nm were collected by CRi Nuance systems.  
MGC803 cells incubated with FA-GO-Ce6 for 24 
h were washed with PBS and fixed in 4% glutaralde-
hyde solution for 1 h at 4 °C. The cells were postfixed 
in 1% osmium tetroxide for 1 h at room temperature 
and  washed.  Then,  cells  were  scraped  and  concen-
trated in 2.5% agar in 0.05 M cacodylate buffer. The 
obtained samples were then treated with 2% uranyl 
acetate solution for 1 h and subsequently dehydrated 
by means of ethanol/water solutions, with increasing 
ethanol  content  and  embedded  in  epoxy  resin.  The Theranostics 2011, 1 
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samples were cut at 60 nm (ultrathin sections) with an 
ultramicrotome. Ultrathin sections were transferred to 
the 300 mesh copper grid and stained with 5% uranyl 
acetate. The copper grid was observed on a transmis-
sion electron microscope (TEM, Joel JEM-1230) at 100 
kV. 
Cytotoxicity assessment 
MGC803 cells (3 × 103 cells per well) were seeded 
in 96-well plates and incubated overnight at 37 °C in a 
humidified  5%  CO2  atmosphere.  After  being  rinsed 
with PBS (pH 7.4), the cells were incubated with 100 
μL  of  varying  concentration  of  different 
nano-composites prepared above for 24 h at 37 °C in 
the dark under the same conditions. Then cells were 
rinsed with PBS and incubated another 48 h. Cell via-
bility  was  determined  by  the  colorimetric  3-(4, 
5-dimethylthiazol-2-yl)-2,  5-diphenyltetrazolium 
bromide (MTT) assay [36-38]. Cells were rinsed with 
PBS  and  then  incubated  with  culture  medium  con-
taining 0.5 mg mL-1 MTT reagent for 3 h. The medium 
was then removed and the formazan crystals formed 
were dissolved in 100 μL of DMSO. The absorbance at 
492 nm for each well was recorded by a microplate 
reader. 
In vitro PDT effects 
Two 96-well plates were set up as dark control 
and experimental group and these plates were seed-
ed, exposed identically to the plates prepared for the 
cytotoxicity  assessment.  The  cells  in  experimental 
group were then rinsed again with PBS and immersed 
in 100 μL of fresh culture medium before being irra-
diated  using  a  632.8  nm  He-Ne  laser  with  energy 
density of ~30 mW/cm2 for 10 min. After irradiation, 
cells were incubated 48 h in a 5% CO2, 95% air hu-
midified incubator at 37 °C. Dark control group keeps 
identical to experimental group  without irradiation. 
PDT effect assay was also determined by MTT assay.  
Statistical analysis 
All data are presented in this article as mean re-
sult ± SD. Statistical differences were evaluated using 
the t test and considered significant at P < 0.05 level. 
All figures shown in this article were obtained from 
three independent experiments with similar results. 
Results 
Synthesis and characterization of GO and 
FA-GO 
GO  was  prepared  using  nature  graphite  pow-
ders as the raw materials through a modified Hum-
mers method [32-34]. The morphology of as-prepared 
GO  was  characterized  by  AFM  (Figure  1a),  TEM 
(Figure 1c), and SEM (Figure 1d).  
 
 
Fig. 1 (a) A tapping mode AFM image of graphene oxide (GO) sheets on mica surface, (b) the height profile of the AFM 
image, (c) TEM image of the GO, and (d) SEM image of the GO. Theranostics 2011, 1 
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The results indicated that the GO existed in the 
sheet-like shapes. The thickness, measured from the 
height profile of the AFM image, Fig. 1b, is about 1.2 
nm, which is consistent with the data reported in the 
literature [32], indicating that the formation of single 
layered GO.  
 
 
Fig.  2 UV-vis spectra of the GO (1) and FA-GO (2) in 
aqueous solution. 
 
The  as-prepared  GO  was  also  determined  by 
FT-IR and UV-vis spectroscopy. The FT-IR spectrum 
of  GO  showed  that  there  are  ester,  hydroxyl,  and 
epoxide  groups  in  the  GO  sheets  (Supplementary 
Material:  Fig.  S1)  [29].  The  raman  spectrum  of  GO 
showed that there are two special peaks: G (the E2g 
mode of sp2 carbon atoms) and D (the symmetry A1g 
mode), indicating that the prepared GO were of high 
purity  (Supplementary  Material:  Fig.  S2)  FA  mole-
cules were conjugated to the GO according to the lit-
erature [28]. One can see that a peak at 232 nm dis-
appears while a new peak at 270 nm appears due to 
the presence of FA in the FA-GO (Fig. 2). 
Spectroscopic properties of FA-GO-Ce6 
We investigated the binding of Ce6 to FA-GO. 
The second generation PS Ce6, was selected because 
of  its  high  photosensitizing  efficacy  and  low  dark 
toxicity, and has been widely incorporated into drug 
carriers for PDT [39-40]. Optical absorption and fluo-
rescence  spectroscopy  were  used  to  analyze  the  in-
teractions between FA-GO and Ce6. Fig. 3(a) shows 
the  absorption  spectra  of  FA-GO,  Ce6,  and 
FA-GO-Ce6 in water. FA-GO without Ce6 show vir-
tually no absorption in the range of 600~800 nm. The 
Ce6 spectrum exhibits a strong Soret absorption at 406 
nm,  and  weak  Q-bands  between  500  and  700  nm. 
UV-vis spectrum of FA-GO-Ce6 revealed Ce6 peaks 
superimposing with the absorption curve of FA-GO, 
suggesting loading of Ce6 onto FA-GO, and also in-
dicating that there is no changes in the Ce6 chromo-
phore  after  carried.  Fig.  3(b)  represents  the  fluores-
cence emission spectra of aqueous solution of FA-GO, 
Ce6,  and  FA-GO-Ce6.  The  fluorescence  emission 
spectra of Ce6 and FA-GO-Ce6 at the same Ce6 con-
centration  are  similar  with  maximum  emission  at 
~652 nm. The results also show drastic fluorescence 
quenching of Ce6 in the FA-GO-Ce6 case, suggesting 
close proximity of Ce6 to the FA-GO sheets. We sug-
gest that the binding of Ce6 onto FA-GO was non-
covalent  in  nature,  driven  by  hydrophobic  interac-
tions and π-π stacking between Ce6 and aromatic re-
gions of the GO sheets. 
 
 
Fig.  3  Absorption  spectra  (a)  and  Fluorescence  emission  spectra  (b)  of  FA-GO  (1),  Chlorin  e6  (Ce6)  (2),  and 
FA-GO-Ce6(3) in water (The inset is the photographs of GO, FA-GO, and FA-GO-Ce6 in tubes). 
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Zeta potential measurements 
To further study the interaction mechanism be-
tween Ce6 and GO, a series of concentrations of GO 
were  chosen  to  interact  with  Ce6  and  the  resultant 
products  were  monitored  by  Zeta  potential  meas-
urement and fluorescence spectroscopy. Zeta poten-
tials and illustration of formation mechanism of the 
GO-Ce6 composite suspensions as a function of the 
component ratio were shown in Fig. 4. An aqueous 
suspension  of  GO  exhibits  a  zeta  potential  of  ca. 
-40.28,  indicative  of  negatively  charged  surfaces 
caused  by  the  presence  of  hydrophilic  carboxyl 
groups. With the increase of Ce6 concentration, the 
zeta  potential  of  the  GO-Ce6  composites  becomes 
more negative (-50.69) due to the aggregation of neg-
atively charged Ce6 on the surface of GO. Each Ce6 
molecule has three carboxyl groups [21], which might 
improve the water solubility of the complex of  Ce6 
and FA-GO. We suggested that there are two different 
hybrid  structures  in  the  solution,  including 
GO-Ce6-GO and Ce6-GO-Ce6 sandwiches, depending 
on the concentration of Ce6 (see Fig. 4). Excitation of 
the GO-Ce6 composites and the control sample at 400 
nm shows a strong quenching (Supplementary Mate-
rial: Fig. S3). The observed luminescence quenching 
indicates that there is a strong interaction between the 
excited  state  of  Ce6  and  GO  in  the  hybrid.  The 
quenching may be attributed to two possible compet-
itive processes: photo-induced electron transfer (PET) 
and energy transfer (ET) [41-44].  
 
 
Fig.  4  Changes  of  the  zeta  potential  of  the  GO-Ce6 
composite suspensions as a function of the component ratio 
and illustration of formation the GO-Ce6 composite. 
Loading Efficiency Measurements 
The loading efficiency of Ce6 was calculated by 
using Ce6 UV calibration curve at 663 nm. The corre-
lation between the UV absorbance at 663 nm and the 
concentration  of  Ce6  was  normalized  by  linear  re-
gression, which showed a well-correlated linear rela-
tionship (R2=0.9948). The standard curve had a good 
linear  relation,  described  by  the  following  typical 
equation: Y=0.07712+27.86047x [14]. The loading effi-
ciency was ~80%, estimated by the typical equation. 
FA-GO shows a higher PSs loading efficiency, com-
pared to other PSs carriers, such as polymeric micelles 
and silica nanoparticles [45], which can be contributed 
to the large specific surface area of GO (two accessible 
sides). The results suggested that FA-GO as nanocar-
riers of Ce6 is a very promising approach for PDT. 
Intracellular distribution 
We  evaluated  the  cellular  selective  uptake  of 
FA-GO-Ce6  with  a  MGC803  cell  in  RPMI-1640  me-
dium without FA, which were carried out contrasted 
to  other  two  groups:  (a)  Cells  were  treated  with 
GO-Ce6 in RPMI-1640 medium without FA; (b) Cells 
were treated with FA-GO-Ce6 in RPMI-1640 medium 
with FA. The fluorescence signal of GO-Ce6 was not 
observed  in  Fig.5b,  which  indicates  nanocarriers 
without  FA  conjugation  didn’t  have  the  targeting 
function.  The  MGC803  cells  incubated  with 
FA-GO-Ce6 and free FA did not exhibit a fluorescence 
signal (Fig.5d), which highly suggests that free FA can 
block the binding of FA-GO-Ce6 with folate receptors 
expressed in the tumor cells. After 30-min incubation 
with FA-GO-Ce6 in RPMI-1640 medium without FA, 
MGC803  cells  displayed  an  intense  homogeneous 
cytoplasmic red fluorescence around the nucleus (Fig. 
5f), indicating selective accumulation of nanocarriers 
in  tumor  cells.  The  strong  fluorescence  intensity  of 
intracellular  FA-GO-Ce6  predicts  available  PDT  ef-
fects, because that PDT damage depends on the up-
take of Ce6 by tumor cells. 
To  further  investigation  on  the  site  of 
FA-GO-Ce6 in MGC803 cells, CRi Nuance multi-
spectral imaging system was used to detect the fluo-
rescence  emission  spectra  of  Ce6,  corresponding  to 
the different sites in the cells. In Fig. 6a, Curve 4 is the 
standard  fluorescence  emission  spectrum  of  Ce6  in 
the cells with maximum emission peak at ~670 nm. In 
Fig. 6b, site of 1, 2 and 3 display the place without 
cells,  the  nucleus,  and  the  cytoplasm,  respectively. 
From Fig. 6a, curve 1 indicates that the autofluores-
cence  has  a  maximum  emission  peak  at  ~560  nm. 
Curve 2 is similar with curve 1, which suggests that 
there is no fluorescence signal in the nucleus. Curve 3 
has two characteristic peaks, a maximum at ~560 nm, Theranostics 2011, 1 
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which corresponds to autofluorescence, and a shoul-
der at ~670 nm, which is attributed to Ce6. These re-
sults prove that there are abundant of FA-GO-Ce6 in 
the cytoplasm. 
 
Fig.  5  Selective  uptake  of  GO-Ce6  and  FA-GO-Ce6  in  MGC803  cells  at  30  min  incubation  of  50  μg/mL  different 
nanocarriers (left: bright field, right: fluorescence). (a,b) Cells were treated with GO-Ce6 in RPMI-1640 medium without 
FA. (c,d) Cells were treated with FA-GO-Ce6 in RPMI-1640 medium with FA. (e,f) Cells were treated with FA-GO-Ce6 in 
RPMI-1640 medium without FA. All cells monitored by fluorescence microscopy. 
 
Fig. 6 The typical fluorescence emission spectra (a) and fluorescence image (b) of Cells treated with FA-GO-Ce6 in 
RPMI-1640 medium without FA. 
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For  comparison,  the  ultrastructure  of  MGC803 
cells was also observed by TEM. As shown in Fig. 7, 
we found that the FA-GO-Ce6 was located both on the 
surface  and  in  the  cytoplasm  of  MGC803  cells. 
Meanwhile,  there  is  no  FA-GO-Ce6  in  the  nucleus. 
The results are consistent with the  fluorescence im-
ages and spectra (Fig. 5 and 6). To the control group, 
no nanocarries can be observed in the cells (Supple-
mentary Material: Fig. S4). The FA-GO-Ce6 was in-
ternalized by cells (Fig. 7 a and b) and transferred by 
vesicles  (Fig.  7  c  and  d).  Subsequently,  some 
FA-GO-Ce6  entered  lysosomes.  We  infer  that 
FA-GO-Ce6 targeted the FA-receptors, and internal-
ized  by  receptor-mediated  endocytosis  through  the 
deformation of the membrance, and then dispersed in 
the cytoplasm of MGC803 cells [46-47].  
 
 
Fig. 7 TEM images of MGC803 cells incubated with 100 μL of FA-GO-Ce6 (50 μg/mL) for 24 h. (a,c) Low magnification; 
(b,d) High magnification. Arrows denote the FA-GO-Ce6. “pm” and “num” stand for plasma membrane and nuclear 
membrane. 
 
 
Cytotoxicity assessment 
The cytotoxicity of FA-GO and FA-GO-Ce6 was 
evaluated via classic MTT assays. After 24-h incuba-
tion with MGC803 cells, we found that FA-GO pos-
sessed  non-toxicity.  Regarding  the  effects  of 
FA-GO-Ce6 on MGC803 cells, the ratio of mFA-GO/mCe6  
above 2:1 exhibited no dark toxicity, cell viability are 
more than 80%. When the ratio of mFA-GO/mCe6 reach to 
1:1, cell viability is less than 50%, the sample exhibited 
obvious cytotoxicity. These results indicated that the 
toxicity depends on the concentration of Ce6.  
In vitro PDT effect 
The  combination  of  24  h  exposure  of  tumor 
MGC803  cells  to  FA-GO-Ce6  and  laser  irradiation 
induced a drug concentration-dependent cytotoxicity 
to MGC803 cells, which was statistically significantly 
different from nonirradiated controls as shown in Fig. 
8. The nonirradiated group displayed more over 80% Theranostics 2011, 1 
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cell viability, indicating that the FA-GO-Ce6 had no 
effects on tumor cells without light exposure. To the 
irradiated group, the ratio of mFA-GO/mCe6 at 2:1 caused 
approximately 90% loss of cell viability, demonstrat-
ing  an  obvious  photodynamic  efficacy.  These  data 
suggest that the FA-GO-Ce6 nanocarrier has a high 
possibility for PDT. 
 
 
Fig.  8  In  vitro  photodynamic  efficacy  of  FA-GO-Ce6. 
MGC803 cells were incubated with 0–100 μM FA-GO-Ce6 
for 24 h at 37 ˚C in the dark prior to irradiation for 10 min 
with 632.8-nm He-Ne laser. Cell viability was determined 
by MTT assay. Data represent mean ± SD (n = 3). P < 0.05 
for nonirradiated group versus irradiated group. 
 
Discussion 
According  to  the  results  mentioned  above,  we 
suggest one possible interaction mechanism between 
FA-GO-Ce6 and MGC803 cells, shown  in  Scheme 3 
(Fig. C). The whole process includes three steps: (1) 
The FA-GO-ce6 was endocytosed into cytoplasm and 
formed endosomes via the folate receptors mediated 
pathway;  (2)  When  the  endosomes  were  gradually 
turned  into  lysosomes,  Ce6  was  released  from 
FA-GO-Ce6 due to the change of microenvironment 
in lysosomes (pH 4~5); (3) the released Ce6 got away 
from the lysosomes into the cytosol. Subsequently, the 
photodynamic efficacy was achieved upon irradiation 
of appropriate wavelength and dosage. 
We have demonstrated that a novel drug deliv-
ery system based on FA-conjugated GO could be de-
veloped with good solubility and low cytotoxicity for 
targeting PDT. The PS Ce6 has been effectively loaded 
into the system via hydrophobic interactions and π-π 
stacking. The nanocarriers can significantly increase 
the accumulation of PS in tumor cells and lead to a 
remarkable  photodynamic  effect  on  MGC803  cells. 
The  results  indicate  the  potential  applications  of 
FA-conjugated GO in targeting PDT. 
Further development of GO-based drug delivery 
system, the size of GO should be controlled, and the 
surface of GO should be modify to prevent fluores-
cence  quenching  of  PSs  with  GO  and  improve  the 
photodynamic effect. Currently, we have successfully 
prepared  poly  (N-vinyl  pyrrolidone)  modified  na-
noscale GO (< 50 nm) as PS carriers, which are ongo-
ing to assess for in vivo imaging and targeting PDT in 
our  lab.  Additionally,  due  to  the  strong  optical  ab-
sorbance of GO in the near-infrared region, GO have 
been  used  for  photo-thermal  therapy  (PTT)  with 
low-power NIR laser [31]. Based on our studies, if the 
GO-based PDT combined with PTT, could bring novel 
opportunities  to  the  next  generation  of  combined 
cancer  treatment.  With  the  irradiation  of  the  single 
wavelength  laser,  dual-model  therapy  platform  is 
desirable development and has great potential in the 
biomedical application. 
 
 
 
Fig. C. Scheme 3. FA-GO-Ce6 endocytosed by MGC803 
cells, endosome-containing FA-GO-Ce6 complexes were 
located around the nucleus, Ce6 escaped from the endo-
some into the cytoplasm. 
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